Update on tuberous sclerosis complex.
Torres
V E
VE
Mayo Clinic/Mayo Foundation, Rochester, Minn., USA. vicente.torres@mayo.edu
King
B F
BF
McKusick
M A
MA
Bjornsson
J
J
Zincke
H
H
D000328:Adult; D018207:Angiomyolipoma / Q000209:etiology; D015174:Epidural Neoplasms / Q000209:etiology; D005260:Female; D006801:Humans; D007674:Kidney Diseases / Q000209:etiology; D052177:Kidney Diseases, Cystic / Q000209:etiology; D007680:Kidney Neoplasms / Q000209:etiology; D009154:Mutation; D011506:Proteins / Q000235:genetics; D012097:Repressor Proteins / Q000235:genetics; D014402:Tuberous Sclerosis / Q000150:complications* / Q000175:diagnosis / Q000628:therapy; D000077004:Tuberous Sclerosis Complex 1 Protein; D000077005:Tuberous Sclerosis Complex 2 Protein; D025521:Tumor Suppressor Proteins
D011506:Proteins; D012097:Repressor Proteins; D000077004:Tuberous Sclerosis Complex 1 Protein; D000077005:Tuberous Sclerosis Complex 2 Protein; D025521:Tumor Suppressor Proteins